242 related articles for article (PubMed ID: 37576864)
1. Multisite and multitimepoint proteomics reveal that patent foramen ovale closure improves migraine and epilepsy by reducing right-to-left shunt-induced hypoxia.
Dong B; Lu Y; He S; Li B; Li Y; Lai Q; Li W; Ji S; Chen Y; Dai L; Chen L
MedComm (2020); 2023 Aug; 4(4):e334. PubMed ID: 37576864
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter Patent Foramen Ovale Closure Is Effective in Alleviating Migraine in a 5-Year Follow-Up.
He YD; Yan XL; Qin C; Zhang P; Guo ZN; Yang Y
Front Neurol; 2019; 10():1224. PubMed ID: 31803135
[No Abstract] [Full Text] [Related]
3. Risk mitigation in divers with persistent (patent) foramen ovale.
Wilmshurst P
Diving Hyperb Med; 2019 Jun; 49(2):77-78. PubMed ID: 31177512
[TBL] [Abstract][Full Text] [Related]
4. Frequency of migraine headache relief following patent foramen ovale "closure" despite residual right-to-left shunt.
Jesurum JT; Fuller CJ; Kim CJ; Krabill KA; Spencer MP; Olsen JV; Likosky WH; Reisman M
Am J Cardiol; 2008 Oct; 102(7):916-20. PubMed ID: 18805122
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic value of patent foramen ovale closure for drug-resistant epilepsy: A case series report.
Ji S; Dong B; Tang Y; Li H; Lai W; Li Y; Chen Y; Peng A; Chen L
Epilepsia Open; 2024 May; ():. PubMed ID: 38742825
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of patent foramen ovale diagnosis with transcranial Doppler.
Anzola GP
Eur J Ultrasound; 2002 Nov; 16(1-2):11-20. PubMed ID: 12470846
[TBL] [Abstract][Full Text] [Related]
7. The Influence of Patent Foramen Ovale on the Clinical Features of Migraine without Aura: A Cross-Sectional Study.
Tong Q; Yao Y; Xia Y; Chen Z; Ji G; Chen L; Jin R; Dong W
Int J Gen Med; 2023; 16():3645-3654. PubMed ID: 37637709
[TBL] [Abstract][Full Text] [Related]
8. Impact of right-to-left shunt and transcatheter closure on the clinical features of migraine.
He Q; Zhang Y; Wang F; Li C; Guo R; Li X; Luan B; Zhao H; Meng L; Chen H; Meng L
Int J Neurosci; 2020 Mar; 130(3):270-275. PubMed ID: 31549584
[No Abstract] [Full Text] [Related]
9. Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine: The PREMIUM Trial.
Tobis JM; Charles A; Silberstein SD; Sorensen S; Maini B; Horwitz PA; Gurley JC
J Am Coll Cardiol; 2017 Dec; 70(22):2766-2774. PubMed ID: 29191325
[TBL] [Abstract][Full Text] [Related]
10. Effect of Residual Interatrial Shunt on Migraine Burden After Transcatheter Closure of Patent Foramen Ovale.
Ben-Assa E; Rengifo-Moreno P; Al-Bawardy R; Kolte D; Cigarroa R; Cruz-Gonzalez I; Sakhuja R; Elmariah S; Pomerantsev E; Vaina LM; Ning M; Buonanno FS; Hung JW; Inglessis I; Palacios IF
JACC Cardiovasc Interv; 2020 Feb; 13(3):293-302. PubMed ID: 32029246
[TBL] [Abstract][Full Text] [Related]
11. The efficacy and safety of patent Foramen Ovale Closure for Refractory Epilepsy (PFOC-RE): a prospectively randomized control trial of an innovative surgical therapy for refractory epilepsy patients with PFO of high-grade right-to-left shunt.
Shuming J; Hua L; Yusha T; Lei C
BMC Neurol; 2023 Jul; 23(1):282. PubMed ID: 37501155
[TBL] [Abstract][Full Text] [Related]
12. Association of patent foramen ovale with epilepsy: A hospital-based case-control study.
Tang Y; Ji S; Li H; Dong B; Li Y; Zhu C; Chen L
Epilepsia Open; 2023 Sep; 8(3):1075-1083. PubMed ID: 37422851
[TBL] [Abstract][Full Text] [Related]
13. Transcatheter closure of patent foramen ovale: a new migraine treatment?
Morandi E; Anzola GP; Angeli S; Melzi G; Onorato E
J Interv Cardiol; 2003 Feb; 16(1):39-42. PubMed ID: 12664816
[TBL] [Abstract][Full Text] [Related]
14. Intermediate and long-term results of transcatheter closure of patent foramen ovale using the amplatzer patent foramen ovale occluder: one case of pulmonary embolism irrespective of patent foramen ovale closure.
Yoon JH; Kim JS; Lee DH; Shim EJ; Lee SY; Min KS; Cho DJ; Lee HR
Korean Circ J; 2011 Jul; 41(7):356-62. PubMed ID: 21860636
[TBL] [Abstract][Full Text] [Related]
15. Impact of transcatheter closure of patent foramen ovale in the evolution of migraine and role of residual shunt.
Biasco L; Infantino V; Orzan F; Vicentini S; Rovera C; Longo G; Chinaglia A; Belli R; Allais G; Gaita F
J Cardiol; 2014 Nov; 64(5):390-4. PubMed ID: 24713153
[TBL] [Abstract][Full Text] [Related]
16. Visual migraine aura with or without headache: association with right to left shunt and assessment following transcutaneous closure.
Mojadidi MK; Khessali H; Gevorgyan R; Levinson RD; Tobis JM
Clin Ophthalmol; 2012; 6():1099-105. PubMed ID: 22888208
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial.
Mattle HP; Evers S; Hildick-Smith D; Becker WJ; Baumgartner H; Chataway J; Gawel M; Göbel H; Heinze A; Horlick E; Malik I; Ray S; Zermansky A; Findling O; Windecker S; Meier B
Eur Heart J; 2016 Jul; 37(26):2029-36. PubMed ID: 26908949
[TBL] [Abstract][Full Text] [Related]
18. Residual shunt after patent foramen ovale closure: preliminary results from Italian patent foramen ovale survey.
Caputi L; Butera G; Anzola GP; Carminati M; Carriero MR; Chessa M; Onorato E; Rigatelli G; Sangiorgi G; Santoro G; Spadoni I; Ussia GP; Vigna C; Zanchetta M; Parati E;
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e219-26. PubMed ID: 23352683
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of patent foramen ovale closure for treating migraine: a prospective follow-up study.
Qi Y; Zhang Y; Luo X; Cheng G; Du Y; Liu R; Xie H; Cheng Y; Guo Y; Luo G
J Investig Med; 2021 Jan; 69(1):7-12. PubMed ID: 32928904
[TBL] [Abstract][Full Text] [Related]
20. Impact of Percutaneous Closure of Interatrial Shunts on Migraine Attacks: Single-Operator Series and Review of the Literature.
Manolis AS
Rev Recent Clin Trials; 2017; 12(2):129-138. PubMed ID: 28356032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
